Surrozen grabs $33M, joins startups looking to spark a comeback in regenerative med
In another sign that the long, cold winter for regenerative medicine may be coming to an end, The Column Group led a $33 million …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
